This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moley, J. F. Articles by Brodeur, G. M. Search for Related Content PubMed PubMed Citation Articles by Moley, J. F. Articles by Brodeur, G. M.

Low Frequency of ras Gene Mutations in Neuroblastomas, Pheochromocytomas, and Medullary Thyroid Cancers¹

Departments of Surgery [J. F. M., M. B. B., S. A. W.] and Pediatrics [G. M. B.], Washington University School of Medicine, St. Louis, Missouri 63110; Pediatric Oncology Group, St. Louis, Missouri 63110 [G. M. B.]; and Laboratory of Cellular and Biochemical Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [B. A. S., J. L. B.]

Little is known about the prevalence and significance of ras gene activation in neural crest tumors such as neuroblastomas, pheochromocytomas, and medullary thyroid cancers (MTCs). Therefore, we analyzed DNA from 10 human neuroblastoma cell lines and 10 primary human pheochromocytomas for activating mutations in N-ras, H-ras, and K-ras. We also studied DNA from 24 primary neuroblastomas and 10 MTCs for N-ras mutations. ras genes were analyzed by direct sequencing of specific DNA fragments amplified by the polymerase chain reaction. With the exception of the SK-N-SH cell line, the examined ras gene sequences were normal in all the neuroblastomas, pheochromocytomas, and MTCs tested. A single point mutation was identified at codon 59 (GCT^ala ACT^thr) in one N-ras allele in an SK-N-SH subline. Interestingly, this mutation is different from the activating codon 61 mutation which resulted in the initial identification of N-ras from SK-N-SH DNA. Therefore, we analyzed the sequences of earlier passages and sublines of the SK-N-SH cell line, but mutations at codon 59 or 61 were not detected, suggesting that neither mutation was present in the primary tumor. Our results indicate that N-ras mutations may occur spontaneously during in vitro passage of cell lines but rarely, if ever, occur in primary neuroblastomas, pheochromocytomas, and MTCs. In addition, we have not found H-ras or K-ras mutations in any neuroblastoma cell line or primary pheochromocytoma.

¹ This work was supported in part by NIH Grants CA-39771, CA-01027, and CA-05887 (G. M. B.), CA-31553, and CA-08748 (J. L. B.), Veterans Administration Research Advisory Group Grant 0001 (J. F. M.), the Kleberg Foundation (J. L. B.), and the Children's United Research Effort against Cancer (G. M. B.).

² To whom requests for reprints should be addressed, at the Department of Surgery, Washington University School of Medicine, 4960 Audubon Avenue, St. Louis, MO 63110.

Received 8/23/90. Accepted 1/ 8/91.

This article has been cited by other articles:

				C. Takahashi and M. E. Ewen Genetic Interaction between Rb and N-ras: Differentiation Control and Metastasis Cancer Res., October 1, 2006; 66(19): 9345 - 9348. [Abstract] [Full Text] [PDF]

				P. Bachireddy, P. K. Bendapudi, and D. W. Felsher Getting at MYC through RAS Clin. Cancer Res., June 15, 2005; 11(12): 4278 - 4281. [Full Text] [PDF]

				S. Yaari, J. Jacob-Hirsch, N. Amariglio, R. Haklai, G. Rechavi, and Y. Kloog Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest Clin. Cancer Res., June 15, 2005; 11(12): 4321 - 4330. [Abstract] [Full Text] [PDF]

				C. Kitanaka, K. Kato, R. Ijiri, K. Sakurada, A. Tomiyama, K. Noguchi, Y. Nagashima, A. Nakagawara, T. Momoi, Y. Toyoda, et al. Increased Ras Expression and Caspase-Independent Neuroblastoma Cell Death: Possible Mechanism of Spontaneous Neuroblastoma Regression J Natl Cancer Inst, March 6, 2002; 94(5): 358 - 368. [Abstract] [Full Text] [PDF]

				J. M. Maris and K. K. Matthay Molecular Biology of Neuroblastoma J. Clin. Oncol., July 1, 1999; 17(7): 2264 - 2264. [Abstract] [Full Text] [PDF]